UBS Group AG has notified Bang & Olufsen A/S that its shareholding and voting rights have fallen below 5% as of July 1, 2026. UBS now holds 6,784,164 shares, representing 4.60% of the total share capital and voting rights in Bang & Olufsen. This update is in accordance with the Danish Capital Markets Act, which requires disclosure of major shareholdings. The reduction in UBS's stake may influence shareholder dynamics but does not indicate immediate strategic changes for Bang & Olufsen.
The "Diabetic Retinopathy - Pipeline Insight, 2026" report reveals that more than 50 companies are developing over 55 drugs targeting diabetic retinopathy, a leading cause of vision loss in diabetics. Key drugs in late-stage development include Tarco...
Christian Dior SE disclosed its monthly update on the total number of shares and voting rights composing its share capital as of June 30, 2026. The company reported 180,507,516 total shares and a gross total of 356,945,619 voting rights, with a net t...
The osteosarcoma treatment pipeline features over 25 companies developing more than 32 drugs, highlighting strong R&D activity in this bone cancer field. Key drugs in late-stage trials include HS-20093, an antibody-drug conjugate targeting B7-H3, and...
The Shenzhen Chamber of Commerce, led by President Lin Hui, visited Munich to attend The smarter E Europe exhibition, focusing on new energy collaboration between China and Europe. The delegation engaged with European companies on photovoltaics, ener...
Flexible Solutions International has traded its remaining 19.9% equity in FL LLC to secure exclusive rights to manufacture and sell four agricultural products across Central and South America, the Caribbean, and south of the Mexico-US border. This fo...
